Dosage forms: oral solution (1 mg/mL), oral tablet (10 mg; 15 mg; 2 mg; 20 mg; 30 mg; 5 mg), oral tablet, disintegrating (10 mg; 15 mg)Drug class: Atypical antipsychotics Medically reviewed by Philip Thornton, DipPharm. Last updated on Aug 26, 2024....
tablet;oral | prinston inc aripiprazole | 阿立哌唑 | 202683 | tablet;oral | orbion pharms aripiprazole | 阿立哌唑 | 204838 | tablet;oral | amneal pharms aripiprazole | 阿立哌唑 | 206251 | tablet;oral | accord hlthcare abilify | 阿立哌唑 | 021436 | tablet;oral | otsuka aripiprazole ...
Aripiprazole oral solution may be given at same dose on mg-per-mg basis as the tablet strengths of the drug up to a dose of 25 mg. However, if oral solution is used in patients receiving 30-mg tablets, use a dose of 25 mg of the oral solution.Dosing of aripiprazole orally ...
(Abilify Discmelt), anda 1-mg/mL oral solution. Unlike the other atypical antipsychotics,aripiprazole exhibits partial agonist activity at D2, D3,D4, and 5-HT1Areceptors, and antagonist action at 5-HT2Areceptors.Although aripiprazole exhibits a low incidence ofEPS, the compound occupies about ...
Table 4: ABILIFY DISCMELT Orally Disintegrating Tablet Presentations ABILIFY® (aripiprazole) Oral Solution (1 mg/mL) is a clear, colorless to light-yellow solution, supplied in child-resistant bottles along with a calibrated oral dosing cup. ...
675 mg/2.4 mL prefilled syringe (459 mg of aripiprazole) Schizophrenia Indicated for treatment of schizophrenia Oral 10-15 mg/day orally initially; may increase after 2 weeks at each dose strength; not to exceed 30 mg/day orally when administered as tablet formulation; efficacy not significantly...
mg/day, when administered as the tablet formulation; however, doses higher than 10 mg/day or 15 mg/day were not more effective than 10 mg/day or 15 mg/day. Dosage increases should generally not be made before 2 weeks, the time needed to achieve steady-state[seeClinical Studies (14.1)...
The example below illustrates how an applicant used a 505(b)(2) application to modify the route of administration, dosage form, and dose schedule of a brand tablet. An example of a drug using the 505(b)(2) pathway is Alkermes’ Aripiprazole lauroxil (Aristada) extended-release injectable ...
of 10 to 30 mg/day, when administered as the tablet formulation; however, doses higher than 10 or 15 mg/day were not more effective than 10 or 15 mg/day. Dosage increases should generally not be made before 2 weeks, the time needed to achieve steady-state[see Clinical Studies (14.1)...
ANNEXI SUMMARYOFPRODUCTCHARACTERISTICS 1 1.NAMEOFTHEMEDICINALPRODUCT ABILIFY5mgtablets ABILIFY10mgtablets ABILIFY15mgtablets ABILIFY30mgtablets 2.QUALITATIVEANDQUANTITATIVECOMPOSITION ABILIFY5mgtablets Eachtabletcontains5mgofaripiprazole. Excipientwithknowneffect 67mglactosepertablet ABILIFY10mgtablets Eachtabletcontains...